rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGCAGGGCACTGAAGCTTTCTTTGGACAA	CASSVGQGTEAFF	In	VDJ	18	558	0.13429602888086642	0.18513603185136032	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	4	2	0	23	39	-1	41	46			01,02										Vb 1	CASSVGQGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGGGGGAGGGGTGATTCACCCCTCCACTTTGGGAAC	CASSRGRGDSPLHF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	9	0	8	3	3	23	35	45	38	48			01,02										Vb 1	CASSRGRGDSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD02-01*02	TCRBJ01-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCATCGGGACTAGCGCACAAGAGACCCAGTACTTCGGGCCA	CASSIGTSAQETQYF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	6	2	3	2	23	35	48	38	50			01,02			01,02							Vb 1	CASSIGTSAQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTAAGGTCGGGTACTGTTTTTTGGCAGT	CASS*GRVLFF	Stop	VDJ	4	113	0.027196149217809867		33	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	4	13	2	1	29	45	51	47	52						01,02							Vb 16	CASS*GRVLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD02-01	TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTCCTACGAGCAGTACTTCGGGCCG	CASSHSYEQYF	In	VJ	3	89	0.021419975932611312	0.029528865295288653	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	0	0	0	0	29	-1	-1	-1	43													Vb 16	CASSHSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCACTGCATACGGGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	89	0.021419975932611312		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	2	2	7	1	29	39	52	46	53													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQGGETQYF	In	VDJ	2	74	0.017809867629362215	0.0245520902455209	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	1	4	0	0	29	-1	-1	43	49													Vb 16	CASSQGGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCGGAATCAGCCCCAGCATTTTGGTGAT	CASSQDRNQPQHF	In	VDJ	1	30	0.007220216606498195	0.009953550099535502	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	4	1	0	29	46	-1	47	50						01,02							Vb 16	CASSQDRNQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCCATAACAGCCTCTGACCTTCTGGCGCTTTCTTTGGACAA	CASHNSL*PSGAFF	Stop	VDJ	1	27	0.006498194945848376		42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	5	11	4	16	29	38	46	42	62													Vb 16	CASHNSL*PSGAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCATTCGGACAGGGCGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	0.0033694344163658243		38	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	3	2	3	3	29	36	47	39	50													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGCCTATTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVDAYSSYNEQFF	In	VDJ	1	21	0.005054151624548736	0.006967485069674851	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	0	8	3	24	36	47	44	50						01,02								CASSVDAYSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATGACGACTTAGGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASR*RLRHE*KTYGYTF	Stop	VDJ	1	17	0.004091456077015644		54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	5	18	24	35	44	40	62						01,02								CASR*RLRHE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGCCTGGAATGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSGPGMRE*KTYGYTF	Stop	VDJ	1	11	0.002647412755716005		54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	4	0	22	24	-1	40	36	62														CASSGPGMRE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCACGTCCGGGACAGGGGACGGAAACACCATATATTTTGGAGAG	CASSTSGTGDGNTIYF	In	VDJ	1	33	0.007942238267148015	0.010948905109489052	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	4	6	2	18	30	46	36	48														CASSTSGTGDGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCATGTATCGCTGTGCCAGAAACAGGAGGTGAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	23	0.005535499398315283		53	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-06	01	9	3	4	5	2	18	18	26	33	28	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01		TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTAGGGTTTCCAGTCCATCATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	0.0038507821901323704		47	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	5	4	6	7	18	34	43	40	50														X+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCATGTATCGCTGTGCCAGCGGAACCCCAGGGATAGTTCAGCCCCAGCATTTTGGTGAT	CASGTPGIVQPQHF	In	VDJ	1	12	0.002888086642599278	0.003981420039814201	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	3	6	7	5	18	27	39	34	44														CASGTPGIVQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCGCAACATCACGAGGCAAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	43	0.010348977135980746		56	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	11	1	5	11	8	22	35	50	46	58														X+TCRBV07-04+TCRBJ02-06	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCTCAGGGGACAATCAGCCCCAGCATTTTGGTGAT	CAWSVSGDNQPQHF	In	VDJ	1	34	0.008182912154031288	0.0112806901128069	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	3	2	1	26	40	48	42	49													Vb 20	CAWSVSGDNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGATAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	0.005054151624548736		37	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	3	0	4	26	-1	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGGGTGGGCCTTTTAACTATGGCTACACCTTCGGTTCG	CAWSVRGGPFNYGYTF	In	VDJ	1	18	0.004332129963898917	0.005972130059721301	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	1	1	9	26	40	46	41	55													Vb 20	CAWSVRGGPFNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGCAGGACAGCCGGAACCCTGAAGCTTTCTTTGGACAA	CASSQQDSRNPEAFF	In	VDJ	8	242	0.058243080625752106	0.08029197080291971	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	6	3	8	23	37	46	40	54														CASSQQDSRNPEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGAACAAGGGGACTACAATGAGCAGTTCTTCGGGCCA	CTSSQEQGDYNEQFF	In	VDJ	1	39	0.009386281588447653	0.012939615129396152	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	3	3	1	23	40	48	43	49														CTSSQEQGDYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACAGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSQQGGTEAFF	In	VDJ	1	17	0.004091456077015644	0.00564034505640345	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	2	4	1	5	0	2	23	-1	45	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQQGGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGACAGGACCTCCGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSDRTSGANEKLFF	In	VDJ	1	16	0.0038507821901323704	0.0053085600530856005	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	4	3	0	10	23	-1	41	35	51														CASSDRTSGANEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGTCTTCCCTATTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	YSSVFPIGQSRANVLTF	In	VDJ	1	34	0.008182912154031288	0.0112806901128069	51	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	5	11	5	22	32	48	43	53														YSSVFPIGQSRANVLTF+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCAACTTGTACGGGTAGGTCCGTACAATGAGCAGTTCTTCGGGCCA	CASTQLVRVGPYNEQFF	In	VDJ	5	144	0.034657039711191336	0.047777040477770406	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	4	4	11	8	25	35	50	46	58						01,02							Vb 3	CASTQLVRVGPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGATACAGGACTGGTACGACTGAAGCTTTCTTTGGACAA	CASSSGYRTGTTEAFF	In	VDJ	1	33	0.007942238267148015	0.010948905109489052	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	3	4	5	6	9	25	38	49	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGYRTGTTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGACTAGCGGGGGAGGGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	0.0048134777376654635		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	7	1	5	25	39	52	40	57													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGACAGGCAATCAGCCCCAGCATTTTGGTGAT	CASGTGNQPQHF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	5	2	0	0	25	-1	-1	34	41													Vb 3	CASGTGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGGATCTAGCGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	0.007701564380264741		53	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	0	4	1	18	35	48	39	49														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCGAGGGTCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSEGPTGELFF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	39	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	4	0	3	20	-1	37	32	40			01,02											CASSEGPTGELFF+TCRBV07-08+TCRBJ02-02	TCRBV07-08	TCRBD02-01*02	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACAGGTGAATTTTCGCACAAATACGCAGTATTTTGGCCCA	CASRQVNFRTNTQYF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	4	7	0	15	23	-1	39	34	54													Vb 12	CASRQVNFRTNTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGACAGGGGCTCACCCCCTCCACTTTGGGAAC		Out	VDJ	1	9	0.0021660649819494585		38	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	13	0	5	23	-1	44	36	49													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAAGTAGCGGGGGGTTCCCAGGAGCAGTACTTCGGGCCG	CASREVAGGSQEQYF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	7	5	7	23	34	49	39	56													Vb 12	CASREVAGGSQEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGCGGGGGGAGGGAATGAGCAGTTCTTCGGGCCA	CAISEAGGGNEQFF	In	VDJ	1	34	0.008182912154031288	0.0112806901128069	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	1	7	0	4	23	-1	46	38	50													Vb 12	CAISEAGGGNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGCTACTATGGCTACACCTTCGGTTCG	CASSDSYYGYTF	In	VDJ	3	84	0.020216606498194945	0.027869940278699403	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	3	1	2	27	38	44	39	46			01,02										Vb 17	CASSDSYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTCCTGGGATTTTTTCCCAATGGTCTACTGAAGCTTTCTTTGGACAA	CASSISPGIFSQWSTEAFF	In	VDJ	3	82	0.019735258724428398	0.027206370272063702	57	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	0	8	5	6	17	24	39	49	45	66			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISPGIFSQWSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCGGGGGGGATCAAAGATACGCAGTATTTTGGCCCA	CASRAGGIKDTQYF	In	VDJ	1	46	0.011070998796630566	0.015262110152621102	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	5	0	5	27	-1	48	38	53			01,02										Vb 17	CASRAGGIKDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGGAACACAGATACGCAGTATTTTGGCCCA	CASSIVGNTDTQYF	In	VDJ	1	44	0.01058965102286402	0.014598540145985401	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	8	2	2	1	27	43	49	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGGACAGGGTATGGAAACACCATATATTTTGGAGAG	CASSPGTGYGNTIYF	In	VDJ	1	31	0.007460890493381468	0.01028533510285335	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	3	3	2	27	39	51	42	53			01,02										Vb 17	CASSPGTGYGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCCGGGAATCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASNPGIDSNQPQHF	In	VDJ	1	25	0.006016847172081829	0.00829462508294625	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	8	3	0	3	5	27	37	45	40	50			01,02										Vb 17	CASNPGIDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCACAGATACGCAGTATTTTGGCCCA	CASSIGTDTQYF	In	VDJ	1	19	0.00457280385078219	0.0063039150630391505	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	6	1	0	0	27	-1	-1	41	43			01,02			01,02							Vb 17	CASSIGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTACAGATACGCAGTATTTTGGCCCA	CASSIGTDTQYF	In	VDJ	1	18	0.004332129963898917	0.005972130059721301	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	0	10	3	1	1	27	41	44	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGAGACAGGCCGATAGCCAAAAACATTCAGTACTTCGGCGCC	CASS*DRPIAKNIQYF	Stop	VDJ	1	15	0.0036101083032490976		48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	4	0	3	5	27	39	48	42	53			01,02										Vb 17	CASS*DRPIAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACATTCTATGGCTACACCTTCGGTTCG	CASSTTFYGYTF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	6	4	1	2	27	40	45	41	47			01,02										Vb 17	CASSTTFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGTCGATCTTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	2	72	0.017328519855595668		50	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	3	6	5	12	5	26	39	54	51	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCTTCAGGGGAGTGAGCAGTTCTTCGGGCCA	CASSLLQGSEQFF	In	VDJ	2	57	0.013718411552346571	0.01891174518911745	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	9	6	2	24	36	48	42	50		TCRBV24-01,TCRBV24-or09_02												CASSLLQGSEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACCCGAGAGGGATTAAACTACAAGCAGTACTTCGGGCCG		Out	VDJ	2	51	0.01227436823104693		43	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	8	8	11	26	34	47	42	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGGGCAGGGGAGAGACCCAGTACTTCGGGCCA	CASSQKGRGETQYF	In	VDJ	2	48	0.011552346570397111	0.015925680159256803	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	4	5	0	26	41	-1	46	52		TCRBV03-01,TCRBV03-02												CASSQKGRGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCGGGGACCATATCGGAGCGGGTGGCTACACCTTCGGTTCG	CSARPGDHIGAGGYTF	In	VDJ	1	45	0.010830324909747292	0.014930325149303252	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	6	4	7	18	0	26	37	-1	55	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPGDHIGAGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGCGGTTGAATGAAAAACTGTTTTTTGGCAGT	CASSFGRLNEKLFF	In	VDJ	1	45	0.010830324909747292	0.014930325149303252	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	3	8	0	5	1	5	26	40	45	41	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGRLNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCATCGTGCATATCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG	CASIVHISRKTYGYTF	In	VDJ	1	44	0.01058965102286402	0.014598540145985401	48	TCRBV05						TCRBJ01	TCRBJ01-02	01	6	2	7	4	19	0	19	29	-1	48	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIVHISRKTYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05		TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGTAGCGCTGCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	37	0.008904933814681108		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	6	5	2	17	26	38	45	40	62		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGTGGATGAGCAGTTCTTCGGGCCA	CASSQGVDEQFF	In	VDJ	1	36	0.008664259927797834	0.011944260119442602	36	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	6	1	8	0	3	26	-1	45	40	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCGGGGGGGCCTGGCGGAGACCCAGTACTTCGGGCCA	CSARVRGGLAETQYF	In	VDJ	1	33	0.007942238267148015	0.010948905109489052	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	0	5	1	7	26	39	49	40	56		TCRBV20-01,TCRBV20-or09_02												CSARVRGGLAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGCAGGGTGAACACTGAAGCTTTCTTTGGACAA	XASSQGRVNTEAFF	In	VDJ	1	27	0.006498194945848376	0.008958195089581952	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	0	1	0	22	38	-1	39	44	TCRBV01,TCRBV04													XASSQGRVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGTTCCTAGGGCCTCTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	0.006498194945848376		46	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	5	3	6	8	5	26	42	54	50	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGACAAGGTACGAGCAGTACTTCGGGCCG	CASSATRYEQYF	In	VDJ	1	26	0.006257521058965102	0.008626410086264101	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	4	2	3	26	38	44	40	47		TCRBV03-01,TCRBV03-02												CASSATRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCGGGACTACACCGGGGAGCTGTTTTTTGGAGAA	CSANRDYTGELFF	In	VDJ	1	25	0.006016847172081829	0.00829462508294625	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	3	3	0	26	36	-1	39	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSANRDYTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCGCTAAATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	0.006016847172081829		46	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	9	0	5	0	17	26	-1	41	38	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACTGGCCGGACAGGGGGCCTTGAGCTGTTTTTTGGAGAA	CASTGRTGGLELFF	In	VDJ	1	24	0.005776173285198556	0.007962840079628402	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	0	11	6	3	23	33	50	39	53	TCRBV02,TCRBV09													CASTGRTGGLELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTACACAGGGGACGGCTACACCTTCGGTTCG	CSATYTGDGYTF	In	VDJ	1	24	0.005776173285198556	0.007962840079628402	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	8	5	2	26	36	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSATYTGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGGGGTGTCGAGCAGTACTTCGGGCCG	CASSQGRGVEQYF	In	VDJ	1	22	0.00529482551143201	0.0072992700729927005	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	6	1	3	26	42	49	43	52		TCRBV03-01,TCRBV03-02												CASSQGRGVEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGGCAGGGTGGCCGGGGAGCTGTTTTTTGGAGAA	CATSDFGRVAGELFF	In	VDJ	1	21	0.005054151624548736	0.006967485069674851	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	6	3	3	24	41	49	44	52		TCRBV24-01,TCRBV24-or09_02												CATSDFGRVAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACGCAGACAGGTCGGGAGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	0.0048134777376654635		46	TCRBV20						TCRBJ01	TCRBJ01-04	01	2	2	4	7	5	7	26	38	49	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCAAACTCGTTAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	18	0.004332129963898917		56	unresolved						TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	18	30	49	46	54	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTAGGGTATCGTGGCTACACCTTCGGTTCG	CASSQDVGYRGYTF	In	VDJ	1	18	0.004332129963898917	0.005972130059721301	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	5	3	7	3	5	26	43	50	46	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVGYRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCGCTCGGGCGGGGGCCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	0.004091456077015644		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	2	2	6	3	26	39	52	45	55	TCRBV03,TCRBV12													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACAACAGGGGGCGGGATAGCTTTCTTTGGACAA	CASTTGGGIAFF	In	VDJ	1	15	0.0036101083032490976	0.004976775049767751	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	3	0	10	5	5	24	31	45	36	50		TCRBV24-01,TCRBV24-or09_02												CASTTGGGIAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATAGAACAGCAGCCCCAGCATTTTGGTGAT	CASSLIEQQPQHF	In	VDJ	1	14	0.0033694344163658243	0.0046449900464499	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	5	7	5	0	26	41	-1	46	50		TCRBV12-03,TCRBV12-04												CASSLIEQQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASSSSYNEQFF	In	VDJ	1	13	0.003128760529482551	0.0043132050431320505	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	2	0	3	0	26	37	-1	40	43		TCRBV20-01,TCRBV20-or09_02												CSASSSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCACACCCGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	12	0.002888086642599278		49							TCRBJ01	TCRBJ01-04	01	0	3	6	0	1	5	18	35	39	36	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04			TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTAGTTTATACCAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	0.002888086642599278		40	TCRBV24						TCRBJ02	TCRBJ02-05	01	11	4	5	1	11	0	24	31	-1	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGCCAACCGCCCTGACAGGGGACAAATGAGCAGTTCTTCGGGCCA	CASSQPP*QGTNEQFF	Stop	VDJ	1	12	0.002888086642599278		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	2	7	7	3	26	41	56	48	59	TCRBV03,TCRBV05													CASSQPP*QGTNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGACCAATCCGCTGAAAAACTGTTTTTTGGCAGT	CASSLDQSAEKLFF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	5	2	7	7	3	8	26	38	44	41	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDQSAEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCTCCGGGACCTCTGGAAACACCATATATTTTGGAGAG	CASSSGTSGNTIYF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	42	unresolved						TCRBJ01	TCRBJ01-03	01	5	0	7	0	3	0	26	38	-1	41	46	TCRBV03,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCCGATGCCCTAGCGAGGGAGCAGTACTTCGGGCCG	CASSPDALAREQYF	In	VDJ	1	10	0.0024067388688327317	0.0033178500331785005	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	6	7	9	3	19	31	46	40	49	TCRBV05,TCRBV11					01,02								CASSPDALAREQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGCGCCGGCTTACTATGGCTACACCTTCGGTTCG	CSARDAPAYYGYTF	In	VDJ	1	10	0.0024067388688327317	0.0033178500331785005	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	9	0	3	6	2	26	40	49	46	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDAPAYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGGACAGCTTCACTCTAACTATGGCTACACCTTCGGTTCG	CSARDPGQLHSNYGYTF	In	VDJ	1	10	0.0024067388688327317	0.0033178500331785005	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	0	3	7	26	40	50	43	57		TCRBV20-01,TCRBV20-or09_02												CSARDPGQLHSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTAGTTCGGCGGGCAGTAACTATGGCTACACCTTCGGTTCG	CASSSSAGSNYGYTF	In	VDJ	1	10	0.0024067388688327317	0.0033178500331785005	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	1	6	3	24	36	47	42	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSSSAGSNYGYTF+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCCCACAGGCCCCATTTGTGGGCTATGCGGTTTGGACAA	CASSLAPHRPHLWAMRF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	17	5	21	18	35	45	40	66	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAPHRPHLWAMRF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGGCAGTAGGTGTCGAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	25	0.006016847172081829		49	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-06	01	6	3	6	5	13	5	32	40	56	53	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV08-02+TCRBJ02-06	TCRBV08-02*01		TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGAGGGGGCCAACGTCCTGACTTTCGGGGCC	CSVREGANVLTF	In	VDJ	1	20	0.0048134777376654635	0.006635700066357001	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	8	2	4	0	0	25	-1	-1	34	40													Vb 4	CSVREGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAAAGGACTAGCGGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASKGLAGPQETQYF	In	VDJ	1	23	0.005535499398315283	0.007631055076310551	45	TCRBV12	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	1	3	1	2	2	22	32	46	34	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASKGLAGPQETQYF+TCRBV12-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGTCAGGTGAAAAACTGTTTTTTGGCAGT	CASSYGSGEKLFF	In	VDJ	1	20	0.0048134777376654635	0.006635700066357001	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	4	7	4	0	23	38	-1	42	46		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYGSGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CGACTCGGCYRTGTATCKCTGTGCCAGAAGTTAGACAGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	16	0.0038507821901323704		43	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	2	2	2	6	0	18	26	-1	32	40		TCRBV07-05,TCRBV07-06												X+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCACGGACTAGCGGGGGGCTGGAGACCCAGTACTTCGGGCCA	CASSPRTSGGLETQYF	In	VDJ	1	14	0.0033694344163658243	0.0046449900464499	48	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	5	4	3	19	31	49	35	52		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSPRTSGGLETQYF+TCRBV05-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAAGTGGACTAGCGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	0.003128760529482551		38	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	1	4	3	3	0	23	30	-1	33	44		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGGATGTTCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSYSDVRTGELFF	In	VDJ	1	12	0.002888086642599278	0.003981420039814201	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	0	1	8	5	0	7	28	-1	48	45	55		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDVRTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGGGGGTGACTAGCGGGGAGCAGACCCAGTACTTCGGGCCA	CASRGVTSGEQTQYF	In	VDJ	1	12	0.002888086642599278	0.003981420039814201	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	6	6	3	28	39	56	45	59		TCRBV06-04,TCRBV06-08												CASRGVTSGEQTQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTGGGACAGTCAAGAGACCCAGTACTTCGGGCCA	CASSWDSQETQYF	In	VDJ	1	15	0.0036101083032490976	0.004976775049767751	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	2	1	1	23	35	43	36	44													Vb 22	CASSWDSQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGAGTCTAGCAGAATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	0.0036101083032490976		46	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	7	3	4	5	23	39	48	43	53						01,02							Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGAGGACTCTGGAAACACCATATATTTTGGAGAG	CASREDSGNTIYF	In	VDJ	1	15	0.0036101083032490976	0.004976775049767751	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	10	1	0	0	1	23	-1	39	34	40													Vb 22	CASREDSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCGGGACGGACTAACTATGGCTACACCTTCGGTTCG	CASSPGRTNYGYTF	In	VDJ	1	34	0.008182912154031288	0.0112806901128069	42	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-02	01	4	0	7	0	1	3	29	42	48	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGRTNYGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01		TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTAGGGGAGGGGACGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	0.009867629362214199		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	0	2	4	5	23	40	51	44	56													Vb 7.1	X+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTGAACAGGGGGCCACTGAAGCTTTCTTTGGACAA	CASSEQGATEAFF	In	VDJ	1	26	0.006257521058965102	0.008626410086264101	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	4	3	0	23	34	-1	37	46													Vb 7.1	CASSEQGATEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCCCGGACTATTTCTCACTGATACGCAGTATTTTGGCCCA	CASSPGLFLTDTQYF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	9	6	4	9	26	37	47	41	56			01,02			01,02							Vb 12	CASSPGLFLTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTCCAGACAGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSSRQPSGANVLTF	In	VDJ	2	66	0.01588447653429603	0.021897810218978103	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	4	2	18	30	39	34	41														CATSSRQPSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGCAGGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGAGGGNQPQHF	In	VDJ	2	69	0.01660649819494585	0.02289316522893165	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	1	2	5	2	18	32	44	37	46														CASSLGAGGGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACACTCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	0.007942238267148015		41	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	3	6	1	2	3	18	30	35	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTATAGGAAGCGGGGGCTTTATAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	0.0069795427196149215		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	2	4	5	6	18	33	46	38	52														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCTCTTGAGGCCAACGTCCTGACTTTCGGGGCC	CASSSSLEANVLTF	In	VDJ	1	13	0.003128760529482551	0.0043132050431320505	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	2	8	6	8	0	18	31	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSLEANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTCCCCAGGGAAGGTCGGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	0.002888086642599278		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	5	7	9	18	32	44	39	53														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCAGGGTCTTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGLAGELFF	In	VDJ	1	12	0.002888086642599278	0.003981420039814201	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	6	4	5	18	32	41	36	46														CASSLGQGLAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATTACCGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSHYRGAYEQYF	In	VDJ	1	9	0.0021660649819494585	0.0029860650298606504	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	2	6	0	18	30	-1	36	43														CASSHYRGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCGGTGTGGGGTAGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	50	0.012033694344163659		46	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	1	6	2	8	7	4	26	42	53	49	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAACAGGGACATACACTGAAGCTTTCTTTGGACAA	CASGPTGTYTEAFF	In	VDJ	1	30	0.007220216606498195	0.009953550099535502	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	3	6	1	26	38	50	44	51														CASGPTGTYTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAATGGGACACACGGATCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	0.006016847172081829		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	6	0	2	7	20	35	43	37	50														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATGGACAGGGGAGAGGGAAGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDGQGRGKYTGELFF	In	VDJ	1	22	0.00529482551143201	0.0072992700729927005	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	3	3	10	20	35	47	38	57														CASSQDGQGRGKYTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTAGCGGGGGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSVAGGPSTDTQYF	In	VDJ	1	37	0.008904933814681108	0.01227604512276045	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	0	2	3	23	34	47	36	50														CASSVAGGPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGCGACTGACCCCTACGAGCAGTACTTCGGGCCG	CASSYSATDPYEQYF	In	VDJ	1	29	0.0069795427196149215	0.009621765096217651	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	2	3	4	23	40	47	43	51						01,02								CASSYSATDPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTACTAGAAACAGATACGCAGTATTTTGGCCCA	CASSYLLETDTQYF	In	VDJ	1	28	0.006738868832731649	0.0092899800928998	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	8	3	2	2	23	38	45	40	47						01,02								CASSYLLETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCCGGGACAGCAAGTTACGAGCAGTATTTCGGGCCG	CASTPGTASYEQYF	In	VDJ	1	24	0.005776173285198556	0.007962840079628402	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	16	5	17	23	33	45	38	62														CASTPGTASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAGGGGTGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASTRGGGNQPQHF	In	VDJ	1	11	0.002647412755716005	0.0036496350364963502	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	2	1	5	23	33	40	34	45														CASTRGGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGCTCCGGGACAGGGTTCCCCTACGAGCAGTACTTCGGGCCG	CASSSGTGFPYEQYF	In	VDJ	1	10	0.0024067388688327317	0.0033178500331785005	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	3	2	7	4	23	31	47	38	51														CASSSGTGFPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGTATTGGGAACATTTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSCIGNI*KTYGYTF	Stop	VDJ	2	56	0.013477737665463297		51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	6	13	24	36	46	42	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSCIGNI*KTYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATATGAATAGGACATTTACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	50	0.012033694344163659		55	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	8	10	24	36	49	44	59													Vb 18	X+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGGTCGTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	0.005535499398315283		41	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	4	5	3	1	1	5	24	37	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7858B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				168	121	35	10	0	119	81	31	7	0	4155	3014	890	251	0	0.14311941	5.43249416	0.109037034	6.14302731				8249	0.0160127338	0.185136035	0.13429603	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:38	Age (Range):65+ Years (Old Age),Age:70 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1186,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 780,type of chemo:carbo/taxol	0.7202380756069819	MSKCC- Snyder- P01-02		132.0	
